(Q42463447)

1 November 2017

Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis (English)

1 reference

1 November 2017

0 references

Verena Brucklacher-Waldert

1

1 reference

1 November 2017

Klarissa Stuerner

2

1 reference

1 November 2017

Manuela Kolster

3

1 reference

1 November 2017

Julia Wolthausen

4

1 reference

1 November 2017

Eva Tolosa

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

1 November 2017

1 reference

1 November 2017

132

1 reference

1 November 2017

Pt 12

1 reference

1 November 2017

3329-3341

1 reference

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

1 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Regulation of immune and autoimmune responses by ICOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Airway neutrophils and interleukin-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

IL-23 promotes maintenance but not commitment to the Th17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

A fluorogenic assay of endogenous phosphatase for assessment of cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

T-bet is essential for encephalitogenicity of both Th1 and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vβ analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP289

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1096/FJ.04-3458FJE

Identifiers

DOI

10.1093/BRAIN/AWP289

1 reference

1 November 2017

1 reference